Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. BioMarin to buy Prosensa in $840 mln deal

    Headlines

    Mon, 24 Nov 2014

    Nov 24 (Reuters) - BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million including milestone payments, aiming to add to its portfolio of drugs to treat rare diseases.

  2. BRIEF-Cosmo Pharmaceuticals to seek shareholders approval for cancellation of treasury shares

    Headlines

    Mon, 24 Nov 2014

    * To seek shareholders approval for the cancellation of up to 576,760 treasury shares at extraordinary shareholders meeting which is to take place on Dec. 22, 2014 Source text for Eikon: Further company coverage:

  3. CORRECTED-Valeant slashes stake in Allergan after losing bid

    Headlines

    Fri, 21 Nov 2014

    Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent, three days after Actavis Plc trumped its offer for the Botox maker.

  4. BRIEF-Newron Pharmaceuticals says safinamide regulatory process in Europe on track

    Headlines

    Fri, 21 Nov 2014

    * Says CHMP review of safinamide MAA is proceeding without delay, with day 180 procedure having been completed, on time

  5. Valeant slashes stake in Allergan after losing bid

    Headlines

    Thu, 20 Nov 2014

    Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.

  6. UPDATE 1-Valeant Pharma says may buy back up to $2 bln worth of securities

    Headlines

    Thu, 20 Nov 2014

    Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities.

  7. Valeant Pharma may buy back up to $2 bln worth of securities

    Headlines

    Thu, 20 Nov 2014

    Nov 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion in senior notes, shares and other securities.

  8. BRIEF-Shenzhen Hepalink Pharma's U.S. unit in deal to invest $30 mln in Cantex Pharmaceuticals

    Headlines

    Thu, 20 Nov 2014

    Nov 20 (Reuters) - Shenzhen Hepalink Pharmaceuticals Co Ltd

  9. UPDATE 1-Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln

    Headlines

    Wed, 19 Nov 2014

    Nov 19 (Reuters) - Pharmaceutical investment firm Royalty Pharma said it would buy royalties on Vertex Pharmaceuticals Inc's cystic fibrosis treatments from Cystic Fibrosis Foundation for $3.3 billion in cash.

  10. UPDATE 1-Synergy Pharma constipation drug succeeds mid-stage trial

    Headlines

    Wed, 19 Nov 2014

    Nov 19 (Reuters) - Synergy Pharmaceuticals Inc said its experimental drug for opioid-induced constipation was found safe and effective in a mid-stage trial.

« Prev12345Next »
Content Partners